Major pharmacy companies agree to settle in nationwide opioid cases


CVS and Walgreens, two of the largest pharmacy chains in the country, have agreed to pay $5 billion each to settle lawsuits throughout the country over allegations of mishandling opioid prescriptions. The companies announced the settlement plan through government filings but need the approval of the myriad of plaintiffs before the deal can go into effect, The New York Times reports.
These settlements can potentially put an end to the decades of lawsuits regarding the role of the drug industry in the opioid epidemic, NPR reports. Opioid overdose was the cause of 80,000 deaths in 2021 alone and approximately 9.5 million Americans reported misusing opioids in 2020, according to CNN. Opioids are painkillers that can be illegal, like heroin, or prescribed by doctors, including morphine, oxycodone, and hydrocodone.
Previously, the companies tried fighting the lawsuits in court; they were unsuccessful, however, when a federal judge ordered them to pay $650 million to two Ohio counties in August, the Times continues. The jury explained that the companies seemed to turn a blind eye to alarming pill quantities and continued to dispense.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
CVS and Walgreens have specified that their willingness to pay settlements does not equate to an admission of wrongdoing. Along with CVS and Walgreens, Walmart has agreed to pay $3 billion in settlements as well.
CVS general counsel Thomas Moriarty said in a statement, "We are committed to working with states, municipalities, and tribes, and will continue our own important initiatives to help reduce the illegitimate use of prescription opioids."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Podcast Reviews: 'The Ex Files' and 'Titanic: Ship of Dreams'
Feature An ex-couple start a podcast and a deep dive into why the Titanic sank
-
Critics' choice: Restaurants that write their own rules
Feature A low-light dining experience, a James Beard Award-winning restaurant, and Hawaiian cuisine with a twist
-
Why is ABC's firing of Terry Moran roiling journalists?
Today's Big Question After the network dropped a longtime broadcaster for calling Donald Trump and Stephen Miller 'world-class' haters, some journalists are calling the move chilling
-
Climate change can impact our gut health
Under the radar The gastrointestinal system is being gutted
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
Orthorexia nervosa: when clean eating goes too far
The Explainer Being healthy is fine, but obsessing over it is dangerous
-
Children's breakfast cereals are getting more unhealthy
Under the radar Your kids may be starting their day with more than a spoonful of sugar
-
A happy gut is a healthy gut. These 5 tips aim to help you achieve that goal.
The Week Recommends A healthy gut is all the rage in wellness circles
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
A tick-borne illness is making its rounds in new parts of America
Under the radar Babesiosis, spread through blacklegged or deer tick bites, is a growing risk